search
Back to results

Cryotherapy Versus Radiofrequency Catheter Ablation Research Program

Primary Purpose

Atrial Fibrillation, Atrial Tachycardia, Wpw

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Cryotherapy
radiofrequency catheter ablation
Sponsored by
St. George's Hospital, London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring catheter ablation techniques

Eligibility Criteria

18 Years - 88 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients under the care of the Arrhythmia Service at St. George's Hospital with one of the studied arrhythmia (PAF, persistent AF etc), awaiting catheter ablation treatment will be eligible for inclusion to the program of research

Exclusion Criteria:

  • Vulnerable patients will be excluded- e.g. active cancer, inability to consent
  • Paediatric patients will not be studied
  • Patients awaiting standard SVT catheter ablation treatment

Sites / Locations

  • St.George's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Cryotherapy

Radiofrequency

Arm Description

Cryotherapy ablation energy will be utilised in the catheter ablation procedure

Radiofrequency ablation energy will be utilised in the catheter ablation procedure

Outcomes

Primary Outcome Measures

Recurrence of the treated arrhythmia at 6 months
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 6 months. The method for recording recurrence will be from Holter or via loop recorder download.
Recurrence of the treated arrhythmia at 12 months
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 12 months. The method for recording recurrence will be from Holter or via loop recorder download.
Recurrence of the treated arrhythmia at 24 months
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 24 months. The method for recording recurrence will be from Holter or via loop recorder download.

Secondary Outcome Measures

The rate of major adverse cerebrovascular and/or cardiovascular complications (defined as MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded
A record of MACCE (MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded for all participants for 24 months
To record the patient quality of life improvement by filling in a Short Form-36 questionnaire
The validated questionnaire is called the General Health Short Form-36 questionnaire. It is a general health questionnaire with 36 questions. The scoring system works from 0-100. The higher the score, the more favourable the general well-being of the patient or participant.

Full Information

First Posted
November 6, 2018
Last Updated
January 24, 2019
Sponsor
St. George's Hospital, London
search

1. Study Identification

Unique Protocol Identification Number
NCT03816033
Brief Title
Cryotherapy Versus Radiofrequency Catheter Ablation Research Program
Official Title
Multi-catheter Cryotherapy Versus Radiofrequency Catheter Ablation for the Treatment of Standard and Resistant Arrhythmias
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2018 (Actual)
Primary Completion Date
June 2021 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St. George's Hospital, London

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A program of research has been set up at St. George's Hospital, London studyng the practicalities of catheter ablation. The current practice of catheter ablation is being studied for a range of arrhythmias including PAF, persistent AF, advanced persistent AF and resistant WPW.
Detailed Description
The study design will be a separate randomised clinical trial for each of the arrhythmias studied. There will be 1:1 randomisation to either the cryotherapy protocol or RF protocol. Arrhythmia patients already under the care of this cardiac centre, who have already opted for catheter ablation treatment will be approached to ask if they will also be willing to participate in this longterm research program. The protocols for each different arrhythmia are in line with current practice and knowledge and utilising current technology. In the program, the investigators have 1 or 2 protocols that mildly differ from conventional use but have already passed through initial experience with publication on this- this is the multi-catheter cryocatheter approach. Acute procedural outcomes, short, medium and longterm success will be recorded for each patient, in addition to patient or participant experience and quality of life outcomes. The catheter ablation research program has passed through ethical panel review in London and has the potential to become a multi-centre study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Atrial Tachycardia, Wpw, Ventricular Tachycardia
Keywords
catheter ablation techniques

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a 1:1 randomised clinical controlled trial or a set of them, in our extensive program of research.
Masking
Outcomes Assessor
Masking Description
The physiologist analysing the Holter results and/or loop recorders for recurrence of arrhythmia will not know the randomised treatment for the study participant.
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cryotherapy
Arm Type
Active Comparator
Arm Description
Cryotherapy ablation energy will be utilised in the catheter ablation procedure
Arm Title
Radiofrequency
Arm Type
Active Comparator
Arm Description
Radiofrequency ablation energy will be utilised in the catheter ablation procedure
Intervention Type
Procedure
Intervention Name(s)
Cryotherapy
Intervention Description
Catheter ablation treatment for the treatment of the studied arrhythmias
Intervention Type
Procedure
Intervention Name(s)
radiofrequency catheter ablation
Intervention Description
Catheter ablation treatment for the treatment of the studied arrhythmias
Primary Outcome Measure Information:
Title
Recurrence of the treated arrhythmia at 6 months
Description
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 6 months. The method for recording recurrence will be from Holter or via loop recorder download.
Time Frame
6 months
Title
Recurrence of the treated arrhythmia at 12 months
Description
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 12 months. The method for recording recurrence will be from Holter or via loop recorder download.
Time Frame
12 months
Title
Recurrence of the treated arrhythmia at 24 months
Description
Recurrence of the treated arrhythmia or related tachycardia will be recorded in a single timeframe of 24 months. The method for recording recurrence will be from Holter or via loop recorder download.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
The rate of major adverse cerebrovascular and/or cardiovascular complications (defined as MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded
Description
A record of MACCE (MI, CVA, vascular, oesophageal trauma, phrenic nerve injury) will be recorded for all participants for 24 months
Time Frame
24 months
Title
To record the patient quality of life improvement by filling in a Short Form-36 questionnaire
Description
The validated questionnaire is called the General Health Short Form-36 questionnaire. It is a general health questionnaire with 36 questions. The scoring system works from 0-100. The higher the score, the more favourable the general well-being of the patient or participant.
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
88 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients under the care of the Arrhythmia Service at St. George's Hospital with one of the studied arrhythmia (PAF, persistent AF etc), awaiting catheter ablation treatment will be eligible for inclusion to the program of research Exclusion Criteria: Vulnerable patients will be excluded- e.g. active cancer, inability to consent Paediatric patients will not be studied Patients awaiting standard SVT catheter ablation treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anu Taiwo, Bsc
Phone
+4420287256606
Email
mtaiwo@sgul.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Lisa Leung, MBChB (Hons), MRCP (UK)
Phone
07952738053
Email
lleung@sgul.ac.uk
Facility Information:
Facility Name
St.George's Hospital
City
London
ZIP/Postal Code
SW170QT
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anu Taiwo, Bsc
Phone
0208 725 6606
Ext
6606
Email
mtaiwo@sgul.ac.uk
First Name & Middle Initial & Last Name & Degree
Mark M Gallagher, MD
First Name & Middle Initial & Last Name & Degree
Lisa WM Leung, MBChB
First Name & Middle Initial & Last Name & Degree
Manav Sohal, MD
First Name & Middle Initial & Last Name & Degree
Zia Zuberi, PHD
First Name & Middle Initial & Last Name & Degree
Abhay Bajpai, MD
First Name & Middle Initial & Last Name & Degree
Anthony Li, MD
First Name & Middle Initial & Last Name & Degree
Mark Norman, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The research data will be kep in a closed system within our NHS centre to the direct care team and researchers. Once anonymised data is available to be presented, it will be presented on an international stage and publications are expected, in respected journals.
Citations:
PubMed Identifier
25946280
Citation
Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P; STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015 May 7;372(19):1812-22. doi: 10.1056/NEJMoa1408288.
Results Reference
background
PubMed Identifier
25281891
Citation
Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Storti C, Montenero AS, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015 Jan;12(1):60-6. doi: 10.1016/j.hrthm.2014.09.063. Epub 2014 Oct 2.
Results Reference
background
PubMed Identifier
26727045
Citation
Hunter RJ, Baker V, Finlay MC, Duncan ER, Lovell MJ, Tayebjee MH, Ullah W, Siddiqui MS, McLEAN A, Richmond L, Kirkby C, Ginks MR, Dhinoja M, Sporton S, Earley MJ, Schilling RJ. Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial). J Cardiovasc Electrophysiol. 2015 Dec;26(12):1307-14. doi: 10.1111/jce.12846. Epub 2015 Nov 25.
Results Reference
background
PubMed Identifier
23475587
Citation
Bisleri G, Rosati F, Bontempi L, Curnis A, Muneretto C. Hybrid approach for the treatment of long-standing persistent atrial fibrillation: electrophysiological findings and clinical results. Eur J Cardiothorac Surg. 2013 Nov;44(5):919-23. doi: 10.1093/ejcts/ezt115. Epub 2013 Mar 8.
Results Reference
background
PubMed Identifier
16461833
Citation
Haissaguerre M, Hocini M, Sanders P, Takahashi Y, Rotter M, Sacher F, Rostock T, Hsu LF, Jonsson A, O'Neill MD, Bordachar P, Reuter S, Roudaut R, Clementy J, Jais P. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation. 2006 Feb 7;113(5):616-25. doi: 10.1161/CIRCULATIONAHA.105.546648.
Results Reference
background
PubMed Identifier
16680548
Citation
Tada H, Yamada M, Naito S, Nogami A, Oshima S, Taniguchi K. Radiofrequency catheter ablation within the coronary sinus eliminates a macro-reentrant atrial tachycardia: importance of mapping in the coronary sinus. J Interv Card Electrophysiol. 2006 Jan;15(1):35-41. doi: 10.1007/s10840-006-6310-2.
Results Reference
background
PubMed Identifier
22588748
Citation
Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.
Results Reference
background
PubMed Identifier
19467519
Citation
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jais P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D; European Heart Rhythm Association (EHRA); Registered Branch of the European Society of Cardiology (ESC); Heart Rhythm Society (HRS); American College of Cardiology (ACC); American Heart Association (AHA). EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009 Jun;6(6):886-933. doi: 10.1016/j.hrthm.2009.04.030. No abstract available.
Results Reference
background
PubMed Identifier
22671922
Citation
Andrade JG, Dubuc M, Guerra PG, Macle L, Mondesert B, Rivard L, Roy D, Talajic M, Thibault B, Khairy P. The biophysics and biomechanics of cryoballoon ablation. Pacing Clin Electrophysiol. 2012 Sep;35(9):1162-8. doi: 10.1111/j.1540-8159.2012.03436.x. Epub 2012 Jun 5.
Results Reference
background

Learn more about this trial

Cryotherapy Versus Radiofrequency Catheter Ablation Research Program

We'll reach out to this number within 24 hrs